Governance Novartis AG

NOVN

CH0012005267

Pharmaceuticals

Market Closed - Swiss Exchange Other stock markets 11:31:11 2026-01-13 am EST			5-day change	1st Jan Change
113.64 ^CHF	-0.18%		+4.74%	+3.69%

Jan. 13	Travere shares fall as US FDA extends review of rare kidney disease drug	RE
Jan. 13	Novartis eyes more bolt-on acquisitions, CEO says	RE

Executive Committee: Novartis AG

Manager

Positions heldSince

Vasant Narasimhan

50 year

Chief Executive Officer

2018-01-31

Teresa Jose

Comptroller/Controller/Auditor

2025-06-30

Shreeram Aradhye

64 year

Chief Tech/Sci/R&D Officer

2022-05-15

Robert Kowalski

58 year

Human Resources Officer

2021-08-31

Charlotte Pamer-Wieser

Corporate Secretary

2011-08-31

Karen Hale

58 year

Compliance Officer	2025-04-13
General Counsel	2021-05-14

Steffen Lang

59 year

Chief Operating Officer

2022-04-03

Harry Werner Kirsch

61 year

Director of Finance/CFO

2013-04-23

Composition of the Board of Directors: Novartis AG

Director

CommitteesSince

Giovanni Caforio

61 year

Compensation Committee
HR Committee
Governance Committee
Nominating Committee

Bridgette Heller

64 year

Compensation Committee Chair	2019-09-12
Audit Committee	2020-02-27
Compensation Committee	2020-02-27
Governance Committee	2021-02-01
Nominating Committee	2021-02-01
Finance Committee

Nancy Andrews

67 year

Governance Committee Chair	2025-05-19
Nominating Committee Chair	2025-05-19
Compensation Committee	2021-01-31

Patrice Bula

70 year

Compensation Committee	2019-02-27
Governance Committee Chair	2019-02-27
Nominating Committee Chair	2019-02-27

Simon Moroney

67 year

Compensation Committee Chair	2020-02-27
Compensation Committee	2021-03-31
Nominating Committee	2021-03-31

Daniel Hochstrasser

66 year

Audit Committee	2022-03-03
Governance Committee	2022-03-03
Nominating Committee	2022-03-03

John Young

62 year

Audit Committee
Governance Committee
Compensation Committee	2025-03-06

Ana de Pro Gonzalo

59 year

Audit Committee	2022-03-03
Compensation Committee	2021-12-03
Audit Committee Chair	2020-05-31

Frans van Houten

65 year

Audit Committee
Governance Committee Chair
Nominating Committee Chair

Liz Doherty

69 year

Audit Committee Chair

2019-05-09

Ton Büchner

61 year

Audit Committee

2018-03-01

Elizabeth McNally

65 year

Director/Board Member

2025-03-06

Latest Appointments: Novartis AG

Jan. 13	Swiss stocks - Factors to watch on January 13	RE
Jan. 12	Kyverna Therapeutics, Inc. Appoints Christi Shaw as Executive Chairperson of the Board, Effective January 12, 2026	CI
Jan. 08	Tango Therapeutics, Inc. Announces Board and Executive Changes	CI
Jan. 08	Tango Therapeutics, Inc. Announces Chief Executive Officer Changes, Effective January 8, 2026	CI
Jan. 05	OKYO Pharma Limited Announces Chief Executive Officer Changes, Effective January 5, 2026	CI
Jan. 05	Gubra Announces Executive Changes	CI
Dec. 11	Tristan Imbert Appointed to Euroapi Board of Directors

More news

Former Officers and Directors: Novartis AG

Insider

Positions held

SinceUntil

Srikant T. Madhav Datar

Director/Board Member	2002-12-31	2020-12-31
Independent Dir/Board Member	2002-12-31	2020-12-31

Pierre Landolt

Director/Board Member	2010-01-07	2018-03-01
Independent Dir/Board Member	2010-01-07	2018-03-01
Corporate Officer/Principal	1995-12-31	2010-01-07

Joseph Jimenez

Director/Board Member	2009-11-01	2010-01-07
Chief Executive Officer	2010-01-31	2017-12-31
Corporate Officer/Principal	2010-01-07	2010-01-25

Jürgen Brokatzky-Geiger

Human Resources Officer	2004-12-31	2014-03-05
Corporate Officer/Principal	2014-03-05	2017-09-30

Wendelin Wiedeking

Director/Board Member	2002-12-31	2014-02-24
Independent Dir/Board Member	2002-12-31	2014-02-24
Corporate Officer/Principal	2002-12-31	2010-01-07

Rolf M. Zinkernagel

Director/Board Member	2010-01-07	2014-02-24
Independent Dir/Board Member	1998-12-31	2014-02-24
Corporate Officer/Principal	1998-12-31	2010-01-07

Alexandre F. Jetzer-Chung

Director/Board Member	2010-01-07	2011-02-21
Corporate Officer/Principal	1995-12-31	2010-01-07

Raymund Breu

Director of Finance/CFO

1996-11-30

2008-12-31

Hans Jörg Reinhardt

Chief Operating Officer	2007-12-31	2009-12-31
Corporate Officer/Principal	2005-12-31	2007-12-31
Chairman	2012-12-31	2025-03-06
Independent Dir/Board Member	2012-12-31	2025-03-06

William Brody

Director/Board Member	2009-02-23	-
Independent Dir/Board Member	2011-08-24	-

Urs Bärlocher

General Counsel

1998-12-31

2007-08-30

Thomas Ebeling

Corporate Officer/Principal

1999-12-31

2006-12-31

Karen Hübscher

Public Communications Contact

1999-12-31

2005-12-31

Andreas von Planta

Director/Board Member	2005-12-31	-
Independent Dir/Board Member	2005-12-31	-

Pierre F. Dodion

Sales & Marketing

2001-12-31

2005-12-31

François Martelet

Corporate Officer/Principal

2003-06-30

2005-06-30

Ian Garland

Corporate Officer/Principal

2005-05-31

Joachim P. H. Schupp

Corporate Officer/Principal

1984-12-31

2004-09-30

Ronen Tamir

Investor Relations Contact	2011-10-27	-
Public Communications Contact	2011-10-27	-
Corporate Officer/Principal	2003-12-31	2011-10-27

Marshall E. Reese

Corporate Officer/Principal

1998-12-31

2003-12-31

Mihael Polymeropoulos

Corporate Officer/Principal

1997-12-31

2002-12-31

Gilbert Wenzel

Corporate Officer/Principal

2000-10-31

2002-12-31

Paul Herrling

Chief Tech/Sci/R&D Officer

2002-10-31

Bruce F. Fleming

Corporate Officer/Principal

2001-05-31

2002-05-31

Silke Zentner

Public Communications Contact

2002-04-04

Fredrik Ollila

Corporate Officer/Principal

2001-12-31

Paolo Baroldi

Corporate Officer/Principal

1997-12-31

2001-12-31

James New

Corporate Officer/Principal

1998-12-31

Helmut Sihler

Director/Board Member

1995-12-31

Birgit Breuel

Corporate Officer/Principal

1995-12-31

Norman Hardman

Chief Tech/Sci/R&D Officer

1995-12-31

Peter Burckhardt

Director/Board Member	2009-12-30	-
Corporate Officer/Principal	1995-12-31	2009-12-30

John McKenna

Corporate Officer/Principal

1989-12-31

Ann Bailey

Public Communications Contact

1981-12-31

Gabor Veres

Corporate Officer/Principal

Siv Lindbratt Börjes

Corporate Officer/Principal

Adrian Hunter

Corporate Officer/Principal

MaryAnn DeMarco

Corporate Officer/Principal

David Metzger

Corporate Officer/Principal

Virginia Jamieson

Corporate Officer/Principal

Max Burger

Chairman	2010-04-20	-
President	2009-07-16	2010-04-20

Ian Stuart Charles Talmage

Corporate Officer/Principal

Michael Horne

Corporate Officer/Principal

John McAdoo

Corporate Officer/Principal

Ian Matthews

Corporate Officer/Principal

Geoff MacKay

Corporate Officer/Principal

Jutta Monika Heim

Corporate Officer/Principal

Peter Thomas Sany

Chief Tech/Sci/R&D Officer

William P. Keane

Corporate Officer/Principal

Nagesh Mahanthappa

Corporate Officer/Principal

Ann Moravick

Corporate Officer/Principal

Bobby Singh

Corporate Officer/Principal

Dominique Cheneval

Corporate Officer/Principal

John H. van Duzer

Corporate Officer/Principal

Randall S. Moore

Corporate Officer/Principal

Eric Wayne Evans

Director of Finance/CFO

Christoph Hüls

Corporate Officer/Principal

Ingrid Duplain

Corporate Secretary

Bruno Heynen

Corporate Secretary

Corinne Hoff

Public Communications Contact

Stuart J. Davie

Chief Tech/Sci/R&D Officer

Günter Frankenne

Director/Board Member

Karel Petrak

Corporate Officer/Principal

Peter E. Carlin

Corporate Officer/Principal

Terry Hart

Corporate Officer/Principal

Geert C. Mudde

Corporate Officer/Principal

Phil Johnson

Corporate Officer/Principal

Malcolm B. Cheetham

Comptroller/Controller/Auditor

James Phillips

Corporate Officer/Principal

Maike July-Grolman

Corporate Officer/Principal

Armin M. Kessler

Sales & Marketing

Hans-Georg Capraro

Corporate Officer/Principal

William J. Rutter

Director/Board Member

Gordon Wright

Corporate Officer/Principal

Jeret Bode

Corporate Officer/Principal

Rob Goshert

Corporate Officer/Principal

Jeffrey Hrkach

Corporate Officer/Principal

Peter Herold

Corporate Officer/Principal

Thomas Littke

Corporate Officer/Principal

John Slevin

Corporate Officer/Principal

Cees Winnips

Corporate Officer/Principal

Humphrey Harte

Corporate Officer/Principal

Age distribution of managers

Parity Men Women

Male	20
Female	8

Of which Executive Committee

Male	6
Female	2

Of which Directors

Male	9
Female	3

Revisions

Révisions CA 1 an

Révisions CA 4 mois

Révisions CA 1 mois

Révisions BNA 1 an

Révisions BNA 4 mois

ESG MSCI

Environnement

Social

Gouvernance

Polémique

Controverses Ethiques

Controverses sur les droits de l'Homme

Controverses Subventions fiscales

Conforme à la finance Islamique

Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales break down by therapeutic area as follows: - oncology (29.3%); - immunology (18.5%); - cardiovascular, renal and metabolic diseases (17%); - neuroscience (9.4%). The remaining net sales (25.8%) are from contract manufacturing of pharmaceutical products. At the end of 2024, Novartis AG had over 30 production sites worldwide. Net sales are distributed geographically as follows: Europe (30.9%), the United States (42%), Asia/Africa/Australasia (20%), Canada and Latin America (7.1%).

Employees

75,883

Sector

Pharmaceuticals

Calendar

Feb. 03 - Q4 2025 Earnings Release

More about the company